Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: A prospective study

Volume: 358, Issue: 9299, Pages: 2113 - 2117
Published: Dec 22, 2001
Abstract
Summary null Background null The plasma concentration of asymmetrical dimethylarginine (ADMA), an inhibitor of nitric-oxide synthase, which has been linked to endothelial dysfunction and atherosclerosis in the general population, is raised in patients with end-stage renal disease and could contribute to the high cardiovascular risk in patients with chronic renal failure. We investigated the relation between cardiovascular risk factors and plasma...
Paper Details
Title
Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: A prospective study
Published Date
Dec 22, 2001
Journal
Volume
358
Issue
9299
Pages
2113 - 2117
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.